HongShan China
Venture CapitalHong Kong, Hong KongSee on the maphongshan.com
HongShan China is a private equity investment firm focused on technology, healthcare, and consumer sectors. It invests from seed and early stages through growth, mergers and acquisitions, and public markets.
- 2
- Portfolio companies on reccy
- 0
- Hiring now
- 0
- Open roles in the portfolio
- Jul 2026
- Latest portfolio round
Hiring now in the portfolio0
Apply on each company's siteNone of their companies on reccy has an open role right now. Browse all neurotech roles
Portfolio on reccy2
From company funding recordsTheir companies, round by round
From company funding records- GestalaChengdu, China
Brain-computer interfaces · Neuromodulation
- Jul 2026Angel · $61.9MLed
- Mar 2026Angel · $21.8M
- BCIFlex (智冉医疗)Beijing, China
Brain-computer interfaces
- Sep 2026Series B · $89.6M
- Feb 2026Series A · $43.4M
- Aug 2025Series A · $41.8M
- Jul 2024Seed
- Aug 2023Angel
- Jan 2023Seed
Rounds marked Led list HongShan China as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Jul 2026
Gestala · Angel $61.9MLead
With C Capital, CEC Data Capital, China Electronics Health Fund, CTS Capital, Dalton Venture, Furong Capital, Gobi Partners, GoldTech Venture Capital, Guosheng Capital, Huaying Capital, Lens Technology, Lingang Sci-Tech Investment, Lingang Technology Investment, Meridian Capital, Seas Capital, Sinovation Ventures
Portfolio in the news
From the Cortex · last 12 months- Mar 2026Gestala Secures $21M in Largest China BCI Angel Round
Gestala · Gestala on LinkedIn
- Jan 2026